CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alza Corporation v. Osmotica Kereskedelmi es Szolgaltato Kft

1:13-cv-01126

Overview

Case Number 1:13-cv-01126
Filing Date 2013-06-24
Status Terminated
Termination Date 2014-06-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand Defendant

Parties

Defendant

Norwich Pharmaceuticals Inc. Operating Company

Represented By

4 Attorneys Listed

Kenneth G. Schuler

Email: kenneth.schuler@lw.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Osmotica Pharmaceutical Corp. Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Osmotica Kereskedelmi es Szolgaltato Kft Operating Company

Represented By

6 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

William A. Rakoczy

Email: wrakoczy@rmmslegal.com

Theodore J. Chiacchio

Email: tchiacchio@rmmslegal.com

Robert M. Teigen

Email: rteigen@rmmslegal.com

Peter J. Curtin

Email: pcurtin@rmmslegal.com

Plaintiff

Janssen Pharmaceuticals Inc. Operating Company

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Alza Corporation NPE (Individual / Inventor)

Represented By

7 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Peter S. Choi

Email: peter.choi@sidley.com

Lisa A. Schneider

Email: lschneider@sidley.com

James A. High

Email: jhigh@sidley.com

Fitz B. Collings

Email: fcollings@sidley.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2011-05-05
1:11-cv-00395

Alza Corporation v. Impax Laboratories, Inc.

U.S. Family Sibling (["US6930129"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8163798
Methods and devices for providing prolonged drug therapy
Filed: 2003-08-12
Issued: 2012-04-24
Expired (Term Ended)
Expires: 2020-10-29
US6919373
Methods and devices for providing prolonged drug therapy
Filed: 1999-02-19
Issued: 2005-07-19
Expired (Term Ended)
Expires: 2019-02-19
US6930129
Methods and devices for providing prolonged drug therapy
Filed: 2001-03-08
Issued: 2005-08-16
Expired (Term Ended)
Expires: 2017-11-21

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

8

Dispositive

4

Granted

0

Denied

0

Pending / Review

8

Motions by Category

Procedural / Extension Motion 4 Motion to Dismiss 4

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
REPLY BRIEF re 20 MOTION to Dismiss filed by Norwich Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 10/07/2013)
Entry #31 • 2013-10-07 Document →
Motion to Dismiss Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 20 MOTION to Dismiss filed by Alza Corporation, Janssen Pharmaceuticals Inc..Reply Brief due date per Local Rules is 1...
Entry #25 • 2013-09-26 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss - filed by Norwich Pharmaceuticals Inc.. (Horwitz, Richard) Modified on 9/10/2013 (nms). (Entered: 09/09/2013)
Entry #20 • 2013-09-09 Document →
Motion to Dismiss Pending / Under Review
OPENING BRIEF in Support re 20 MOTION to Dismiss, filed by Norwich Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 9/26/2013. (Horwitz...
Entry #21 • 2013-09-09 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Respond to Answer, Defenses, and Counterclaims to October 17, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Osmo...
Entry #27 • 2013-10-02 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to September 9, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Osm...
Entry #15 • 2013-07-12 Document →

Docket Entries

(40 total)
Procedural / Extension Motion Pending / Under Review

MOTION for Leave to File Complaint Under Seal - filed by Alza Corporation, Janssen Pharmaceuticals Inc. (Attachments: # 1 Letter to Clerk)(rwc) (Additional attachment(s) added on 6/25/2013: # 2 Civil Cover Sheet) (rwc). (Entered: 06/25/2013)

Entry #1 • 2013-06-24
1
Pleading / Complaint

[SEALED] COMPLAINT - filed against Norwich Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number #19282.) - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(rwc) (Entered: 06/25/2013)

Entry #2 • 2013-06-24
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 06/25/2013)

Entry #3 • 2013-06-24
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/20/13. Date of Expiration of Patent: 7/31/17.Thirty Month Stay Deadline: 11/20/2015. (rwc) (Entered: 06/25/2013)

Entry #4 • 2013-06-24
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,798. (rwc) (Entered: 06/25/2013)

Entry #5 • 2013-06-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc